Jackson secured the party's nod during a convention of roughly 600 delegates, narrowly overcoming a challenge from biopharmaceutical executive Saundra Pelletier. The transition marks a critical pivot for the party as it looks to regain momentum ahead of the midterm elections.
With over $1 million already raised, Jackson is positioning his campaign to challenge Collins on a platform centered on economic affordability, corporate influence, and immigration. As control of the U.S. Senate remains on a razor's edge, this contest has quickly become a focal point for national party strategists looking to shift the balance of power in Washington.





Comments (0)
No comments yet. Be the first!